Suicide Assessment and Prevention Workshop 2021

The suicide rate has increased significantly over the past two decades, with nearly 50,000 people currently dying from suicide in America each year.

To respond to our field’s most pressing clinical challenge, McLean Hospital and the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine asked national suicide experts to present the most recent, cutting-edge advances in suicide-focused assessment and treatment.

This event took place on October 20, 2021.

Watch the sessions on demand below or view the event agenda.

Event Agenda

Welcome Remarks

Scott L. Rauch, MD – President and Psychiatrist in Chief, Rose-Marie and Eijk van Otterloo Chair of Psychiatry, McLean Hospital
Alan F. Schatzberg, MD – Director, Stanford Mood Disorders Center, Stanford School of Medicine

Suicide Prevention Overview: Science and Trends

Christine Moutier, MD – Chief Medical Officer, American Foundation for Suicide Prevention

Overview of Suicide-Focused Assessment

Douglas G. Jacobs, MD – Founder, Stop A Suicide Today; Member, Suicide Advisory Committee, McLean Hospital

Suicide: Basic Facts

Ross J. Baldessarini, MD – Director, International Consortium for Mood & Psychotic Disorders Research, McLean Hospital

Suicide and Special Populations

Tami Benton, MD – Psychiatrist in Chief, Executive Director, and Chair of the Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children’s Hospital of Philadelphia

Safety Planning: A Critical Intervention to Mitigate Suicide Risk

Barbara Stanley, PhD – Director, Suicide Prevention Training, Implementation and Evaluation Program, New York State Psychiatric Institute

Question and Answer Session

Assessment and Prevention of Suicide in Older Adults

Yeates Conwell, MD – Professor and Vice Chair, Department of Psychiatry, University of Rochester Medical Center

Behavioral Health Care Crisis Care: The Role of 988 and Suicide Crisis Centers

Madelyn Gould, PhD, MPH – Irving Philips Professor of Epidemiology in Psychiatry at Columbia University, Vagelos College of Physicians and Surgeons

Innovations in Clinical Assessment and Treatment of Suicide Risk

David Jobes, PhD – Professor of Psychology and Associate Director of Clinical Training, Catholic University of America

Accelerated Theta Burst Repetitive Transcranial Magnetic Stimulation for Suicide Prevention (Clinical Utilization of TMS)

Nolan Williams, MD – Assistant Professor of Psychiatry and Behavioral Sciences, Stanford University School of Medicine

Clinical Utilization of Ketamine in Suicide Prevention: Can We Improve Outcomes?

Alan F. Schatzberg, MD – Director, Stanford Mood Disorders Center, Stanford School of Medicine

Question and Answer Session